Nexium Deceptive Marketing Action Tossed
A federal judge has dismissed a putative class action that alleged AstraZeneca Pharmaceuticals LP engaged in deceptive business practices by orchestrating a misleading marketing campaign for heartburn drug Nexium....To view the full article, register now.
Already a subscriber? Click here to view full article